Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Indiva in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.02.
Current Consensus is
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in Indiva. This N/A consensus rating has held steady for over two years.
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers edibles, capsules and tablets, and vape products under the No Future, Pearls by gron, Bhang Chocolate, Indiva Doppio, Indiva Blips, and Indiva 1432 brands. Indiva Limited is based in Ottawa, Canada.
Read More